Precision Optics Corp., Inc. (POCI)
4.35
-0.02
(-0.46%)
USD |
NASDAQ |
Sep 04, 16:00
4.34
-0.01
(-0.23%)
After-Hours: 20:00
Precision Optics Research and Development Expense (Quarterly) : 0.2673M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.2673M |
| December 31, 2025 | 0.2496M |
| September 30, 2025 | 0.3118M |
| June 30, 2025 | 0.2283M |
| March 31, 2025 | 0.2112M |
| December 31, 2024 | 0.3177M |
| September 30, 2024 | 0.4007M |
| June 30, 2024 | 0.3545M |
| March 31, 2024 | 0.1928M |
| December 31, 2023 | 0.2217M |
| September 30, 2023 | 0.2128M |
| June 30, 2023 | 0.3319M |
| March 31, 2023 | 0.2064M |
| December 31, 2022 | 0.1553M |
| September 30, 2022 | 0.2455M |
| June 30, 2022 | 0.2332M |
| March 31, 2022 | 0.2149M |
| December 31, 2021 | 0.1132M |
| September 30, 2021 | 0.1052M |
| June 30, 2021 | 0.1806M |
| March 31, 2021 | 0.1461M |
| December 31, 2020 | 0.146M |
| September 30, 2020 | 0.1516M |
| June 30, 2020 | 0.1855M |
| March 31, 2020 | 0.3199M |
| Date | Value |
|---|---|
| December 31, 2019 | 0.2286M |
| September 30, 2019 | 0.1522M |
| June 30, 2019 | 0.1574M |
| March 31, 2019 | 0.1216M |
| December 31, 2018 | 0.1254M |
| September 30, 2018 | 0.1008M |
| June 30, 2018 | 0.1216M |
| March 31, 2018 | 0.1264M |
| December 31, 2017 | 0.09M |
| September 30, 2017 | 0.1184M |
| June 30, 2017 | 0.1056M |
| March 31, 2017 | 0.1223M |
| December 31, 2016 | 0.1192M |
| September 30, 2016 | 0.117M |
| June 30, 2016 | 0.1011M |
| March 31, 2016 | 0.1183M |
| December 31, 2015 | 0.1081M |
| September 30, 2015 | 0.1508M |
| June 30, 2015 | 0.1372M |
| March 31, 2015 | 0.1402M |
| December 31, 2014 | 0.1389M |
| September 30, 2014 | 0.0767M |
| June 30, 2014 | 0.1111M |
| March 31, 2014 | 0.133M |
| December 31, 2013 | 0.0921M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| RxSight, Inc. | 9.237M |
| Abbott Laboratories | 892.00M |
| Align Technology, Inc. | 102.03M |
| AngioDynamics, Inc. | 8.178M |
| Accuray, Inc. | 7.707M |